Mylan, Inc. (MYL) Tops Q2 EPS by 7c; Narrows FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts MYL Hot Sheet
Join SI Premium – FREE
Mylan, Inc. (NASDAQ: MYL) reported Q2 EPS of $0.52, $0.07 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.57 billion versus the consensus estimate of $1.5 billion.
Mylan, Inc. sees FY2011 EPS of $1.95-$2.05, versus prior guidance of $1.90-$2.10 and the consensus of $2.00.
Mylan, Inc. sees FY2011 EPS of $1.95-$2.05, versus prior guidance of $1.90-$2.10 and the consensus of $2.00.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cardinal Health (CAH) Tops Q4 EPS by 19c, Misses on Revenue; Offers FY27 EPS Guidance
- Elbit Systems (ESLT) Tops Q3 EPS by 90c
- DarioHealth (DRIO) Tops Q2 EPS by 40c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
